Showing results (541-550 of 560) with videos related to

Sort By:
Pageof 56
Disability and Health Journal|May 5, 2026
First steps toward pain classification among adults with cerebral palsy: A modified Delphi studyMary E Gannotti, David J Kohns, Garey H Noritz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2021
A Phase Ib/II Study of Pepinemab in Combination with Avelumab in Advanced Non-Small Cell Lung CancerMichael R Shafique, Terrence L Fisher, Elizabeth E Evans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2016
PlGF/VEGFR-1 Signaling Promotes Macrophage Polarization and Accelerated Tumor Progression in ObesityJoao Incio, Josh Tam, Nuh N Rahbari, et al.
Cell Metabolism|July 21, 2015
2-Hydroxyglutarate Inhibits ATP Synthase and mTOR SignalingXudong Fu, Randall M Chin, Laurent Vergnes, et al.
Pediatric Neurology|June 1, 2019
Severity Assessment in CDKL5 Deficiency DisorderScott Demarest, Elia M Pestana-Knight, Heather E Olson, et al.
Science Translational Medicine|March 16, 2018
Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2Joao Incio, Jennifer A Ligibel, Daniel T McManus, et al.
JCI Insight|July 3, 2019
S100a4-Cre-mediated deletion of Patched1 causes hypogonadotropic hypogonadism: role of pituitary hematopoietic cells in endocrine regulationYi Athena Ren, Teresa Monkkonen, Michael T Lewis, et al.
Cancer Discovery|June 2, 2016
Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to ChemotherapyJoao Incio, Hao Liu, Priya Suboj, et al.
Advances in Therapy|August 11, 2025
Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension StudyOlivier Sitbon, Sandeep Sahay, Pilar Escribano Subías, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2015
Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignanciesA L Wong, R A Soo, D S Tan, et al.
Pageof 56